Compare CMPX & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | BFS |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 926.7M | 770.9M |
| IPO Year | 2020 | N/A |
| Metric | CMPX | BFS |
|---|---|---|
| Price | $5.77 | $34.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $14.43 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 56.8K |
| Earning Date | 03-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $850,000.00 | N/A |
| Revenue This Year | N/A | $8.14 |
| Revenue Next Year | N/A | $5.75 |
| P/E Ratio | ★ N/A | $30.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $29.16 |
| 52 Week High | $6.88 | $37.89 |
| Indicator | CMPX | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 58.94 |
| Support Level | $4.78 | $31.18 |
| Resistance Level | $5.86 | $35.18 |
| Average True Range (ATR) | 0.31 | 0.63 |
| MACD | -0.11 | -0.07 |
| Stochastic Oscillator | 6.54 | 52.22 |
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.